Skip to content

Pfizer PFE Price / book

Price / book at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
6.2×-1.0×
Eli Lilly logo
Eli LillyLLY
26.3×-20.7×
Johnson & Johnson logo
Johnson & JohnsonJNJ
7.3×+2.1×
Merck & Co. logo
Merck & Co.MRK
6.5×+1.8×
Amgen logo
AmgenAMGN
20.6×-6.3×
Incyte logo
IncyteINCY
3.3×+0.1×

Other financials

Income statement

See full
Revenue$14.5B+5.4%
Gross profit$10.9B+0.3%
Net income$2.7B-9.4%
EPS (diluted)$0.47-9.6%

Balance sheet

See full
Cash & equivalents$1.8B+18.8%
Total debt$64.4B+5.0%
Total equity$90.1B-0.3%
Total assets$207.62B-0.2%

Cash flow

See full
Operating cash flow$2.6B+12.0%
CapEx$436.0M-22.7%
Free cash flow$2.2B+23.0%

Valuation

See full
Market cap$147.73B+11.1%
Enterprise value$210.4B+9.2%
P/E12.2×
P/S2.3×+0.2×

Profitability

See full
Gross margin73.5%+1.2pp
Net margin15.7%

Returns & leverage

See full
Return on equity10.6%
Debt / equity0.7×0.0×
Current ratio1.2×0.0×

Where this comes from

Calculated from Pfizer’s reported figures.

Based on the most recent quarter.

The official record: Pfizer’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pfizer's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pfizer's price / book?
Pfizer (PFE) reported price / book of 1.8× in Q1 2026.
How has Pfizer's price / book changed year-over-year?
Pfizer's price / book increased by 11.4% year-over-year, from 1.6× to 1.8×.
What is the long-term trend for Pfizer's price / book?
Over 4 years (2021 to 2025), Pfizer's price / book has grown at a -17.3% compound annual growth rate (CAGR), from 13.6× to 6.3×.
What does price / book mean?
How the market price compares to the company's accounting net worth.
How do you interpret price / book?
Below 1.0 can flag a market discount to book value (common for distressed or asset-heavy firms); high values reflect intangible value the balance sheet doesn't capture. Most informative for financials and asset-heavy businesses.
How does price / book compare across companies?
A core valuation gauge for banks and insurers; weak for asset-light firms where book value understates economic value.